أهمية التنميط المناعي في تشخيص وإنذار الأمراض الدموية الخبيثة مع التركيز على ابيضاض الدم اللمفاوي المزمن البائي B-CLL
Abstract
أجريت هذه الدراسة على مجموعة من المرضى الذين قبلوا في شعبة أمراض الدم بمشفى الأسد الجامعي باللاذقية. وقد سلطت الضوء على الدور المحوري الذي يلعبه التنميط المناعي بطريقة Flow cytometry (الجريان الخلوي) المجرى لهؤلاء المرضى في الوصول للتشخيص الدقيق وفي توزيعهم ضمن مجموعات تشخيصية فرعية لكل منها خصوصيته العلاجية والإنذارية. وقد ركزت الدراسة على مرضى الإبيضاض اللمفاوي المزمن البائي B-CLL نظراً لأنهم يشكلون 63% من مجموع المرضى. وأظهرت النتائج بأن مرضى B-CLL مع هم أطول بقيا من مرضى B-CLL مع . كذلك بينت دور والعلاقة الوثيقة بين إيجابيته والإنذار الجيد وعلى العكس أظهرت الترابط بين التألق الشديد للغلوبين المناعي الغشائي السطحي smlg والإنذار السيئ .
This study has been carried out on a group of patients admitted to the Hematology Department at Al-Assad University Hospital in Lattakia. We examine the central role of the immunophenotyping performed by Flow cytometry for the appropriate diagnosis and then distributing the patients into different subgroups according to treatment and prognosis for each disease. This study also focuses on B-cell chronic lymphocytic leukemia because it represents 63% of the total patients. The results show that B-CLL patients with CD5+ live longer than patients of B-CLL with CD5-. This paper has also demonstrated the role of CD23 and the close relation between its positivism and good prognosis; in contrast, it has shown the connection between bad prognosis and high presentation of Smlg .
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series
Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in Tishreen University Journal for Research and Scientific Studies - Health Sciences Series . The Readers have the right to send, print and subscribe to the initial version of the article, and the title of Tishreen University Journal for Research and Scientific Studies - Health Sciences Series Publisher
journal uses a CC BY-NC-SA license which mean
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.